Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2017/10/009966
CTRI/2017/10/009966
Completed
未知

An observational study to evaluate haemostasis action of VELSEAL-T in haemophilia patients with external bleeding

Dr Anupam Dutta0 sites48 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Anupam Dutta
Enrollment
48
Status
Completed
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational

Investigators

Sponsor
Dr Anupam Dutta

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients above 18 years of age with haemophilia disorders who require haemostasis control.
  • •2\. Patients who can provide informed consent form in writing and medically in a position to undergo consent for data collection.
  • •3\. Subjects willing and able to comply with the requirements of the study protocol, including the predefined follow\-up evaluations.

Exclusion Criteria

  • •1\. Subjects with medical emergency, where treatment is the priority than the informed consent process and his/her representative deny to participant in the study.
  • •2\. Subjects who cannot provide the informed consent such as unconscious subjects.
  • •3\. The subjects who have been treated with other higher treatment for Haemorrhage control such as Tourniquets for more than 2 hours, Blood or platelet\-rich\-plasma transfusion etc.
  • •4\. Subjects with known possible loss of plasma or blood from other areas than wound such as lacerations, Uterine bleeding, Gastro\-intestinal bleeding etc.
  • •5\. Subjects with an active infection at the injury site.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 2
To stop the bleeding in cut wounds with the help of Spray prepared from plant Eraka .
CTRI/2024/02/063194Parul Institute of Ayurved.
Not yet recruiting
Not Applicable
An observational study to determine haemodynamic stability and renal outcomes in patients undergoing renal transplantation under either BIS monitored Propofol based Total Intravenous Anaesthesia (TIVA) or MAC monitored Sevoflurane based inhalational anaesthesia
CTRI/2024/06/069128Apollo Multispeciality Hositals Ltd
Recruiting
Not Applicable
Safety of Long term Methotrexate use in rheumatoid arthritisHealth Condition 1: null- Rheumatoid arthritis
CTRI/2015/05/005773institutional Dept of Pharmacology IPGMER200
Not yet recruiting
Phase 2
To control intraoperative blood pressure and heart rate changes
CTRI/2022/01/039834Rajendra Institute of Medical Sciences
Active, not recruiting
Phase 1
A study to learn more about bleeding episodes, the use of treatments containing a protein called clotting factor 8 (FVIII), and how the patients felt about their symptoms and pain, in people with hemophilia AHemophilia AMedDRA version: 20.0Level: LLTClassification code 10053753Term: Hemophilia A without inhibitorsSystem Organ Class: 100000004850Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
EUCTR2019-004480-48-NLBayer AG140